PWSA | USA Presents “Hope for the Holidays” Virtual Concert
FOR IMMEDIATE RELEASE
Sarasota, Florida – Prader-Willi Syndrome Association | USA is thrilled to announce its first-ever benefit concert, Hope for the Holidays. The virtual event premiers on YouTube and Facebook live on December 13, 2020 and will help raise funds for PWSA | USA and the Prader-Willi syndrome community. View the concert promo here.
- CMA nominee, Ingrid Andress (www. ingridandress.com/ladylike)
- Sarah Marince (https://www.sarahmarince.com/)
- Lauren Marie Mertens (https://apple.co/2KsiaLP)
- Melody Guy (https://melodyguy.com/music)
The concert will be hosted by renowned stadium announcer, Alan Roach, the voice of the Minnesota Vikings, the Colorado Avalanche, and the Colorado Rapids.
The event is brought to the Prader-Willi syndrome community by PWSA | USA and title sponsor Soleno Therapeutics, Inc. Other sponsors include Levo Therapeutics, Inc. and Harmony Biosciences.
“We couldn’t be more excited to bring this special holiday concert to the Prader-Willi syndrome (PWS) community. It has been such a difficult year for everyone, and many in the rare disease community have struggled navigating the “new normal” brought about by the global pandemic. Our families face extra health and safety concerns, isolation and loneliness, and disruptions in routines and schedules that are especially challenging for children and adults with PWS. The concert is a chance for the entire PWS community to rest and celebrate the beauty and peace of the season.”
Hope for the Holidays will be an hour-long performance streamed on Facebook Live and YouTube Premier on Sunday, December 13th at 7:30 PM EST. After the show, the video will be permanently posted on PWSA | USA’s YouTube page. While the concert is free to watch, viewers are encouraged to make a donation through a featured Donate Now button, or by going to https://www.pwsausa.org/hope-for-the-holidays/.
All proceeds will go to PWSA | USA’s 2020 Angel Drive campaign to empower families with round the clock support and life-saving resources, facilitates advancements in treatments and medications, and helps thousands of individuals and families find hope and support when they need it most.
About Prader‐Willi Syndrome Association |USA
Formed in 1975, Prader‐Willi Syndrome Association | USA is a nonprofit organization that unites individuals and families with professionals and organizations to empower those affected by Prader-Willi syndrome. PWSA | USA supports the PWS community by providing education and support, raising awareness, and funding life-changing research.
About Soleno Therapeutics, Inc.
Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s lead candidate, Diazoxide Choline Controlled-Release (DCCR) tablets, a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is currently being evaluated in a Phase III clinical development program. For more information, please visit www.soleno.life.
About Levo Therapeutics, Inc.
Levo Therapeutics is a biotechnology company dedicated to using genetic insights to advance treatments for Prader-Willi syndrome and related disorders. To learn more about Levo, please visit www.levotx.com.
About Harmony Biosciences
Harmony Biosciences is a commercial stage pharmaceutical company headquartered in Plymouth Meeting, PA and Chicago, IL. The company was established by Paragon Biosciences, LLC, and is focused on providing novel treatment options for people living with rare, neurological disorders who have unmet medical needs. For more information on Harmony Biosciences, please visit the company’s website: www.harmonybiosciences.com.